Abstract
The potentiation of antitumor drugs by their analogues is one of strategies for overcoming cellular resistance to chemotherapy. In attempts to improve the efficacy of 5-fluorouracil (5-FU) and overcome 5-FU resistance, we synthesized new 5- FU derivatives and evaluated the potentiation effect on 5-FU cytotoxicity. 5-Fluorouracil-1-yl-3-butanone (5-FUBO), a newly synthesized 5-FU derivative, significantly potentiated the cytotoxic effect of 5-FU, and the potentiation of 5-FU by 5-FUBO in 5-FU resistant cells was higher than in their drugsensitive parental cells. Surprisingly, it potentiated the cytotoxicities of vincristine and vinblastine. The potentiation of these drugs by 5-FUBO in mutidrugresistant (MDR) cells was more than in their drugsensitive parental cells. It was also shown that 5-FUBO increased the intracellular accumulation of [3H]vincristine in P388/M cells, and this is related with increased cytotoxicity of vincristine. Northern blot analysis showed that the potentiation effect of MDR-related antitumor drugs by 5-FUBO was caused by inhibition of MDRl gene expression. Also, 5-FUBO cytotoxicity in K562 cells was increased significantly upon transformation with c-Ha-ras.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Kim, S., Kang, C., Chung, B. et al. Circumvention of drug resistance in cancer cells by a new fluoropyrimidine analogue. Exp Mol Med 28, 119–123 (1996). https://doi.org/10.1038/emm.1996.18
Published:
Issue Date:
DOI: https://doi.org/10.1038/emm.1996.18